Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score.

Autor:	Hausmann H; Deutsches Herzzentrum Berlin, Berlin, Germany. hhausmann@dhzb.de, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, Sodian R, Kuppe H, Hetzer R
Jazyk:	angličtina
Zdroj:	Circulation [Circulation] 2002 Sep 24; Vol. 106 (12 Suppl 1), pp. I203-6.
Abstrakt:	Background: Over the past decade, the use of a ventricular-assist device (VAD) in patients with postcardiotomy cardiogenic shock has resulted in hospital discharge rates of 25% to 40% and is improving. Nevertheless, indications for and timing of the implantation of a VAD in patients who have received an intra-aortic balloon pump (IABP) remain unclear. Methods and Results: From July 1996 to March 2000, 391 patients with cardiac low-output syndrome who underwent open-heart surgery and had an IABP implanted were analyzed in a retrospective pilot study. The perioperative mortality was 34% (133 patients). Clinical parameters were analyzed 1 hour after IABP support began. Statistical multivariate analysis showed that patients with an adrenaline requirement higher than 0.5 microg x kg(-1) x min(-1), a left atrial pressure >15 mm Hg, urine output <100 mL/h, and mixed venous saturation (SVO(2)) <60% had poor outcomes. Using this data, we developed an IABP score (0 to 5 points) to predict survival early after IABP implantation in cardiac surgery. We evaluated our score by monitoring another 101 patients as a control group prospectively. Additionally, 210 patients who received coronary artery bypass grafting (CABG) exclusively were analyzed. All investigations confirmed the validity of the score. Conclusions: The IABP score can predict survival early after IABP implantation. In patients with a high IABP score, implantation of a VAD should be considered.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu